Business News • PR NewsWire • The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF)

The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF)

The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF)

MELBOURNE, Australia, July 24, 2014 /PRNewswire/ -- Announced at the 20th International AIDS Conference in Melbourne, the agreement seeks to increase access to a promising new HIV medicine in 112 developing countries At the AIDS 2014 conference in Melbourne today, the...

View More : http://www.prnewswire.com/news-releases/the-medicines-patent-pool-mpp-broadens-collaboration-with-gilead-sciences-signs-...

Releted News by prnewswire

Frost & Sullivan: Global Solar Market Continues to Rise and Shine

Occlutech erreicht Nichtigerklärung von St Jude-Patent